Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Automated Screening for Clinically Ascertained Loss of Cerebral Functions in Patients With Severe Brain Damage - an Interventional Cluster Randomized Trial (DETECT-IVE)

NCT06293170 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.

NCT NCT06293170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06293170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Automated Screening for Clinically Ascertained Loss of Cerebral Functions in Patients With Severe Brain Damage - an Interventional Cluster Randomized Trial (DETECT-IVE)
Lead sponsor
Technische Universität Dresden
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 1, 2024
Completion date
November 1, 2026
Enrollment
4,800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

irreversible loss of brain function (ilbf)